Neoadjuvant dose‐modified docetaxel in squamous cell carcinoma of the head and neck: A phase 3 study

Oral Diseases ◽

10.1111/odi.13252 ◽

2020 ◽

Vol 26 (2) ◽

pp. 285-294

Author(s):

Yan Sun ◽

Wei Guo ◽

Yuxian Bai ◽

Minghua Ge ◽

Chaosu Hu ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Squamous Cell ◽

Download Full-text

Improving Healthcare Value in Patients With Stage III-IV Squamous Cell Carcinoma of Head and Neck (HNSCC): Cost and Outcome Comparison of 2 Arms of a Randomized, Phase 3 Trial of Definitive Chemoradiation (ChemoRT)

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2013.06.1323 ◽

2013 ◽

Vol 87 (2) ◽

pp. S501 ◽

Author(s):

J.F. Greskovich ◽

M. Gordian ◽

S.A. Koyfman ◽

R. Lorenz ◽

J. Scharpf ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Squamous Cell ◽

Stage Iii ◽

Phase 3 ◽

Definitive Chemoradiation ◽

Outcome Comparison

Download Full-text

Abstract CT285: KEYNOTE-689: A phase 3 study of neoadjuvant and adjuvant pembrolizumab plus standard of care (SOC) in locally advanced (LA) head and neck squamous cell carcinoma (HNSCC)

10.1158/1538-7445.am2020-ct285 ◽

2020 ◽

Author(s):

Nancy Y. Lee ◽

Ravindra Uppaluri ◽

William Westra ◽

Ezra E. Cohen ◽

Robert I. Haddad ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Squamous Cell ◽

Locally Advanced ◽

Standard Of Care ◽

Neck Squamous Cell Carcinoma ◽

Download Full-text

Nivolumab treatment beyond RECIST‐defined progression in recurrent or metastatic squamous cell carcinoma of the head and neck in CheckMate 141: A subgroup analysis of a randomized phase 3 clinical trial

Cancer ◽

10.1002/cncr.32190 ◽

2019 ◽

Vol 125 (18) ◽

pp. 3208-3218 ◽

Author(s):

Robert Haddad ◽

Fernando Concha‐Benavente ◽

George Blumenschein ◽

Jerome Fayette ◽

Joel Guigay ◽

...

Keyword(s):

Clinical Trial ◽

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Squamous Cell ◽

Subgroup Analysis ◽

Phase 3 ◽

Metastatic Squamous Cell Carcinoma

Download Full-text

Treatment beyond progression with nivolumab in patients with recurrent or metastatic (R/M) squamous cell carcinoma of the head and neck (SCCHN) in the phase 3 checkmate 141 study: A biomarker analysis and updated clinical outcomes

Annals of Oncology ◽

10.1093/annonc/mdx374.001 ◽

2017 ◽

Vol 28 ◽

pp. v372-v373 ◽

Author(s):

R. Haddad ◽

G. Blumenschein ◽

J. Fayette ◽

J. Guigay ◽

A.D. Colevas ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Clinical Outcomes ◽

Squamous Cell ◽

Phase 3 ◽

Treatment Beyond Progression ◽

Biomarker Analysis

Download Full-text

Phase 3 KEYNOTE-412 trial: Pembrolizumab plus chemoradiation (CRT) vs CRT alone for locally advanced head and neck squamous cell carcinoma (LA-HNSCC)

Annals of Oncology ◽

10.1093/annonc/mdx711.077 ◽

2017 ◽

Vol 28 ◽

pp. xi28

Author(s):

J-P Machiels ◽

C-J Yen ◽

L. Licitra ◽

D. Rischin ◽

J. Waldron ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Squamous Cell ◽

Locally Advanced ◽

Neck Squamous Cell Carcinoma ◽

Advanced Head ◽

Download Full-text

Phase 3 trial of pembrolizumab as a first-line treatment in subjects with recurrent/metastatic head and neck squamous cell carcinoma: KEYNOTE-048

Annals of Oncology ◽

10.1093/annonc/mdv514.01 ◽

2015 ◽

Vol 26 ◽

pp. viii5 ◽

Author(s):

A. Klochikhin ◽

R. Greil ◽

E. Cohen ◽

J. Vermorken ◽

K. Harrington ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Squamous Cell ◽

Neck Squamous Cell Carcinoma ◽

Line Treatment ◽

Phase 3 ◽

First Line Treatment

Download Full-text

DAHANCA 10 – Effect of darbepoetin alfa and radiotherapy in the treatment of squamous cell carcinoma of the head and neck. A multicenter, open-label, randomized, phase 3 trial by the Danish head and neck cancer group

Radiotherapy and Oncology ◽

10.1016/j.radonc.2018.02.018 ◽

2018 ◽

Vol 127 (1) ◽

pp. 12-19 ◽

Author(s):

Jens Overgaard ◽

Camilla Molich Hoff ◽

Hanne Sand Hansen ◽

Lena Specht ◽

Marie Overgaard ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Head And Neck Cancer ◽

Cell Carcinoma ◽

Head And Neck ◽

Neck Cancer ◽

Squamous Cell ◽

Darbepoetin Alfa ◽

Phase 3 ◽

Download Full-text

Evaluation of the EGFR-Inhibitor Zalutumumab Given With Primary Curative (Chemo)radiation Therapy to Patients With Squamous Cell Carcinoma of the Head and Neck: Results of the DAHANCA 19 Randomized Phase 3 Trial

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2013.11.021 ◽

2014 ◽

Vol 88 (2) ◽

pp. 465 ◽

Author(s):

J.G. Eriksen ◽

C. Maare ◽

J. Johansen ◽

H. Primdahl ◽

J.F. Evensen ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Radiation Therapy ◽

Cell Carcinoma ◽

Head And Neck ◽

Squamous Cell ◽

Egfr Inhibitor ◽

Download Full-text

Abstract CT157: Treatment beyond progression with nivolumab in patients with recurrent or metastatic squamous cell carcinoma of the head and neck in the phase 3 Checkmate 141 study

10.1158/1538-7445.am2017-ct157 ◽

2017 ◽

Author(s):

Robert Haddad ◽

Robert L. Ferris ◽

George Blumenschein ◽

Jerome Fayette ◽

Joel Guigay ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Squamous Cell ◽

Phase 3 ◽

Treatment Beyond Progression ◽

Metastatic Squamous Cell Carcinoma

Download Full-text

Pembrolizumab plus chemoradiation (CRT) for the treatment of locally advanced head and neck squamous cell carcinoma (LA-HNSCC): Phase 3 KEYNOTE-412 trial

Annals of Oncology ◽

10.1093/annonc/mdx374.056 ◽

2017 ◽

Vol 28 ◽

pp. v392

Author(s):

J-P. Machiels ◽

L. Licitra ◽

D. Rischin ◽

J. Waldron ◽

B. Burtness ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Squamous Cell ◽

Locally Advanced ◽

Neck Squamous Cell Carcinoma ◽

Advanced Head ◽

Download Full-text